Prothena Corporation plc - Ordinary Shares (PRTA) earnings
PRTA earnings moved a median of 0.00% by the close. Quarterly and annual PRTA reports and results, each read against the price at its own news timestamp. Back to the PRTA overview →
30 measured PRTA earnings events.
Where these PRTA earnings landedvs 29 measured PRTA earnings reactions
| Middle 50% of PRTA earnings reactions | -2.14% to +1.99% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 PRTA earnings events with a measured close landed between -2.14% and +1.99%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PROTHENA CORP PUBLIC For: Jun 30 | SEC filing · Form 10-Q | -2.40% | +2.58% | |
| Prothena Reports Second Quarter 2026 Financial Results and Business Highlights | Press release | -2.40% | +2.58% | |
| Prothena to Report Second Quarter 2026 Financial Results on August 6 | Press release | +0.47% | -3.45% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Mar 31 | SEC filing · Form 10-Q | +0.86% | -2.46% | |
| Prothena Reports First Quarter 2026 Financial Results and Business Highlights | Press release | +0.86% | -2.46% | |
| Prothena to Report First Quarter 2026 Financial Results on May 7 | Press release | -0.81% | -3.62% | |
| Form 10-K PROTHENA CORP PUBLIC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.41% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Sep 30 | SEC filing · Form 10-Q | +0.57% | +0.67% | |
| Prothena Reports Third Quarter 2025 Financial Results and Business Highlights | Press release | +0.57% | +0.67% | |
| Prothena to Report Third Quarter 2025 Financial Results on November 6 | Press release | +0.66% | +1.99% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Jun 30 | SEC filing · Form 10-Q | +0.43% | +0.00% | |
| Prothena Reports Second Quarter 2025 Financial Results and Business Highlights | Press release | +0.43% | +0.00% | |
| Prothena to Report Second Quarter 2025 Financial Results on August 4 | Press release | -1.09% | — | |
| Form 10-Q PROTHENA CORP PUBLIC For: Mar 31 | SEC filing · Form 10-Q | +7.98% | +5.84% | |
| Prothena Reports First Quarter 2025 Financial Results and Business Highlights | Press release | +7.98% | +5.84% | |
| Prothena to Report First Quarter 2025 Financial Results on May 8 | Press release | +0.57% | -2.86% | |
| Form 10-K PROTHENA CORP PUBLIC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.27% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Sep 30 | SEC filing · Form 10-Q | +1.21% | -0.75% | |
| Prothena Reports Third Quarter 2024 Financial Results and Business Highlights | Press release | +1.21% | -0.75% | |
| Prothena to Report Third Quarter 2024 Financial Results on November 12 | Press release | -3.84% | +1.61% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -5.08% | |
| Prothena Reports Second Quarter 2024 Financial Results and Business Highlights | Press release | +0.00% | -5.08% | |
| Prothena to Report Second Quarter 2024 Financial Results on August 8 | Press release | -1.48% | +1.00% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Mar 31 | SEC filing · Form 10-Q | -3.27% | -1.57% | |
| Prothena Reports First Quarter 2024 Financial Results and Business Highlights | Press release | -3.27% | -1.57% | |
| Prothena to Report First Quarter 2024 Financial Results on May 8 | Press release | -0.18% | +0.23% | |
| Form 10-K PROTHENA CORP PUBLIC For: Dec 31 | SEC filing · Form 10-K | +0.93% | +0.70% | |
| Form 10-Q PROTHENA CORP PUBLIC For: Sep 30 | SEC filing · Form 10-Q | +0.64% | -2.14% | |
| Prothena Reports Third Quarter 2023 Financial Results and Business Highlights | Press release | +0.64% | -2.14% | |
| Prothena to Report Third Quarter 2023 Financial Results on November 2 | Press release | -0.70% | +4.75% |
Keep exploring
More PRTA: analyst actions → · SEC filings → · PRTA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Addus HomeCare Corporation (ADUS) | 256 | -0.02% | 47% |
| Celldex Therapeutics, Inc. (CLDX) | 256 | +0.04% | 57% |
| Xeris Biopharma Holdings, Inc. (XERS) | 256 | +0.32% | 57% |
| Cerus Corporation (CERS) | 255 | +0.09% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.